Cargando…
Development of a vaccine against the synthetic opioid U-47700
Opioid use disorders and overdose have become a major public health concern in recent years. U-47700, a New psychoactive substances (NPS) opioid, also known as “pinky” or “pink” has been identified as a new threat in the drug supply because of its potency and abuse potential. Conjugate vaccines that...
Autores principales: | Park, Hyeri, Lin, Mingliang, Zhou, Jian, Eubanks, Lisa M., Zhou, Bin, Janda, Kim D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10363602/ https://www.ncbi.nlm.nih.gov/pubmed/37492086 http://dx.doi.org/10.3389/fphar.2023.1219985 |
Ejemplares similares
-
First Case in Italy of Fatal Intoxication Involving the New Opioid U-47700
por: Gerace, Enrico, et al.
Publicado: (2018) -
U-47700 and Its Analogs: Non-Fentanyl Synthetic Opioids Impacting the Recreational Drug Market
por: Baumann, Michael H., et al.
Publicado: (2020) -
U-47700: An Emerging Threat
por: Alzghari, Saeed K, et al.
Publicado: (2017) -
Metabolic Evaluation of Synthetic Opioids on the Example of U-47700 with the Use of In Vitro and In Vivo Methods for Forensic Toxicology Application
por: Rojek, Sebastian, et al.
Publicado: (2023) -
Broadly Neutralizing Synthetic Cannabinoid Vaccines
por: Lin, Mingliang, et al.
Publicado: (2020)